

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | skeletal muscle fiber development (GO:0048741) | 8.59592579 |
| 2 | actin filament-based movement (GO:0030048) | 7.97186021 |
| 3 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 7.35352049 |
| 4 | myotube cell development (GO:0014904) | 7.33969360 |
| 5 | glycogen catabolic process (GO:0005980) | 7.29395010 |
| 6 | plasma membrane repair (GO:0001778) | 7.00570167 |
| 7 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 6.84901999 |
| 8 | glucan catabolic process (GO:0009251) | 6.83437640 |
| 9 | creatine metabolic process (GO:0006600) | 6.78023852 |
| 10 | striated muscle contraction (GO:0006941) | 6.77497216 |
| 11 | skeletal muscle tissue regeneration (GO:0043403) | 6.66616758 |
| 12 | sarcomere organization (GO:0045214) | 6.56707077 |
| 13 | cellular polysaccharide catabolic process (GO:0044247) | 6.37685221 |
| 14 | striated muscle atrophy (GO:0014891) | 6.34229828 |
| 15 | carnitine shuttle (GO:0006853) | 6.30898721 |
| 16 | response to muscle activity (GO:0014850) | 6.04633057 |
| 17 | polysaccharide catabolic process (GO:0000272) | 6.04595550 |
| 18 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 6.03924432 |
| 19 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 5.91212840 |
| 20 | regulation of cell communication by electrical coupling (GO:0010649) | 5.87035357 |
| 21 | myofibril assembly (GO:0030239) | 5.85858513 |
| 22 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 5.83259375 |
| 23 | response to inactivity (GO:0014854) | 5.77916402 |
| 24 | cardiac myofibril assembly (GO:0055003) | 5.74425031 |
| 25 | muscle contraction (GO:0006936) | 5.69703819 |
| 26 | striated muscle adaptation (GO:0014888) | 5.53574932 |
| 27 | muscle atrophy (GO:0014889) | 5.52210678 |
| 28 | cytidine metabolic process (GO:0046087) | 5.45691565 |
| 29 | cytidine catabolic process (GO:0006216) | 5.45691565 |
| 30 | cytidine deamination (GO:0009972) | 5.45691565 |
| 31 | glucan biosynthetic process (GO:0009250) | 5.44814280 |
| 32 | glycogen biosynthetic process (GO:0005978) | 5.44814280 |
| 33 | fatty acid transmembrane transport (GO:1902001) | 5.29777163 |
| 34 | muscle fiber development (GO:0048747) | 5.12793192 |
| 35 | NADH metabolic process (GO:0006734) | 5.07441118 |
| 36 | muscle system process (GO:0003012) | 5.06109435 |
| 37 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 4.89562308 |
| 38 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 4.83088144 |
| 39 | glycogen metabolic process (GO:0005977) | 4.80599624 |
| 40 | cardiac muscle hypertrophy (GO:0003300) | 4.71584213 |
| 41 | glucan metabolic process (GO:0044042) | 4.71091055 |
| 42 | cellular glucan metabolic process (GO:0006073) | 4.71091055 |
| 43 | neuronal action potential propagation (GO:0019227) | 4.68513281 |
| 44 | carnitine transmembrane transport (GO:1902603) | 4.65097702 |
| 45 | actomyosin structure organization (GO:0031032) | 4.61727638 |
| 46 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.57514651 |
| 47 | striated muscle hypertrophy (GO:0014897) | 4.50311697 |
| 48 | muscle adaptation (GO:0043500) | 4.49499322 |
| 49 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.45913562 |
| 50 | fructose metabolic process (GO:0006000) | 4.38433307 |
| 51 | amino-acid betaine transport (GO:0015838) | 4.25098334 |
| 52 | carnitine transport (GO:0015879) | 4.25098334 |
| 53 | response to activity (GO:0014823) | 4.24233874 |
| 54 | muscle organ morphogenesis (GO:0048644) | 4.22267097 |
| 55 | negative regulation of skeletal muscle tissue development (GO:0048642) | 4.21767653 |
| 56 | 2-oxoglutarate metabolic process (GO:0006103) | 4.19018575 |
| 57 | cellular carbohydrate catabolic process (GO:0044275) | 4.11383561 |
| 58 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 4.10727767 |
| 59 | negative regulation of muscle hypertrophy (GO:0014741) | 4.09260257 |
| 60 | neuromuscular synaptic transmission (GO:0007274) | 4.08606009 |
| 61 | muscle hypertrophy (GO:0014896) | 4.02861164 |
| 62 | regulation of coenzyme metabolic process (GO:0051196) | 4.01457122 |
| 63 | regulation of cofactor metabolic process (GO:0051193) | 4.01457122 |
| 64 | cellular response to dexamethasone stimulus (GO:0071549) | 4.01264908 |
| 65 | muscle cell fate commitment (GO:0042693) | 3.98053133 |
| 66 | muscle organ development (GO:0007517) | 3.95339151 |
| 67 | gluconeogenesis (GO:0006094) | 3.93514140 |
| 68 | muscle tissue morphogenesis (GO:0060415) | 3.93438137 |
| 69 | muscle structure development (GO:0061061) | 3.90266842 |
| 70 | regulation of skeletal muscle cell differentiation (GO:2001014) | 3.88897487 |
| 71 | adult heart development (GO:0007512) | 3.79739799 |
| 72 | regulation of relaxation of muscle (GO:1901077) | 3.77056697 |
| 73 | muscle cell cellular homeostasis (GO:0046716) | 3.76727257 |
| 74 | cardiac muscle contraction (GO:0060048) | 3.75573225 |
| 75 | response to dexamethasone (GO:0071548) | 3.75344292 |
| 76 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.73494974 |
| 77 | striated muscle cell development (GO:0055002) | 3.72522847 |
| 78 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.71349098 |
| 79 | myotube differentiation (GO:0014902) | 3.67660936 |
| 80 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.62404718 |
| 81 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.62404718 |
| 82 | skeletal muscle tissue development (GO:0007519) | 3.61796795 |
| 83 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.57033816 |
| 84 | negative regulation of muscle contraction (GO:0045932) | 3.55844654 |
| 85 | hexose biosynthetic process (GO:0019319) | 3.52034960 |
| 86 | negative regulation of cAMP-mediated signaling (GO:0043951) | 3.48196505 |
| 87 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.47779562 |
| 88 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.47779562 |
| 89 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.47128328 |
| 90 | cardiac muscle cell development (GO:0055013) | 3.44766935 |
| 91 | tricarboxylic acid cycle (GO:0006099) | 3.44569586 |
| 92 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.44198593 |
| 93 | muscle hypertrophy in response to stress (GO:0003299) | 3.44198593 |
| 94 | cardiac muscle adaptation (GO:0014887) | 3.44198593 |
| 95 | cellular polysaccharide metabolic process (GO:0044264) | 3.38539153 |
| 96 | striated muscle tissue development (GO:0014706) | 3.38470817 |
| 97 | ubiquinone biosynthetic process (GO:0006744) | 3.37613203 |
| 98 | heart contraction (GO:0060047) | 3.35097178 |
| 99 | heart process (GO:0003015) | 3.35097178 |
| 100 | positive regulation of myoblast differentiation (GO:0045663) | 3.30411518 |
| 101 | relaxation of muscle (GO:0090075) | 3.30023362 |
| 102 | regulation of sulfur metabolic process (GO:0042762) | 3.29778131 |
| 103 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.29636343 |
| 104 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.29111573 |
| 105 | positive regulation of myotube differentiation (GO:0010831) | 3.28640904 |
| 106 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.28041064 |
| 107 | regulation of the force of heart contraction (GO:0002026) | 3.27529153 |
| 108 | regulation of actin filament-based movement (GO:1903115) | 3.26118641 |
| 109 | regulation of striated muscle contraction (GO:0006942) | 3.25934512 |
| 110 | positive regulation of cation channel activity (GO:2001259) | 3.25829170 |
| 111 | myoblast fusion (GO:0007520) | 3.24699040 |
| 112 | syncytium formation by plasma membrane fusion (GO:0000768) | 3.24058637 |
| 113 | cellular polysaccharide biosynthetic process (GO:0033692) | 3.23341500 |
| 114 | neuromuscular junction development (GO:0007528) | 3.19717645 |
| 115 | regulation of sequestering of triglyceride (GO:0010889) | 3.19130224 |
| 116 | polysaccharide biosynthetic process (GO:0000271) | 3.18163876 |
| 117 | muscle cell development (GO:0055001) | 3.16832188 |
| 118 | intracellular lipid transport (GO:0032365) | 3.15303134 |
| 119 | polysaccharide metabolic process (GO:0005976) | 3.10726028 |
| 120 | endoplasmic reticulum organization (GO:0007029) | 3.10228608 |
| 121 | regulation of sequestering of calcium ion (GO:0051282) | 3.09625375 |
| 122 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.09151356 |
| 123 | regulation of myoblast differentiation (GO:0045661) | 3.07596435 |
| 124 | actin-myosin filament sliding (GO:0033275) | 13.0308828 |
| 125 | muscle filament sliding (GO:0030049) | 13.0308828 |
| 126 | regulation of skeletal muscle contraction (GO:0014819) | 12.8486583 |
| 127 | skeletal muscle contraction (GO:0003009) | 11.7389602 |
| 128 | skeletal muscle adaptation (GO:0043501) | 10.8087724 |
| 129 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 10.6986875 |
| 130 | actin-mediated cell contraction (GO:0070252) | 10.6475196 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.22482088 |
| 2 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.51227226 |
| 3 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.50879194 |
| 4 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.44582094 |
| 5 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.28616064 |
| 6 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 2.81405892 |
| 7 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.77215286 |
| 8 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.50252824 |
| 9 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.41165637 |
| 10 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.41165637 |
| 11 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.38424965 |
| 12 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.32112431 |
| 13 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.26247914 |
| 14 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.13164754 |
| 15 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.02065783 |
| 16 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 10.1850544 |
| 17 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.92264603 |
| 18 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.78588051 |
| 19 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.76467149 |
| 20 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.73068465 |
| 21 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.70935521 |
| 22 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.60489623 |
| 23 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.60486850 |
| 24 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.58976966 |
| 25 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.55022600 |
| 26 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.52873520 |
| 27 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.50074350 |
| 28 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.48780680 |
| 29 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.46774653 |
| 30 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.40588643 |
| 31 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.40169466 |
| 32 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.39157445 |
| 33 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.38638700 |
| 34 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.37524878 |
| 35 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.36076459 |
| 36 | SA1_27219007_Chip-Seq_Bcells_Human | 1.36074930 |
| 37 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.35645231 |
| 38 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.33849965 |
| 39 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.32090980 |
| 40 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.30606942 |
| 41 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.28595698 |
| 42 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.27724528 |
| 43 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.26632421 |
| 44 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.25446223 |
| 45 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.25422723 |
| 46 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.24594931 |
| 47 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.23965533 |
| 48 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.23476697 |
| 49 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.22653797 |
| 50 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.22549271 |
| 51 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.22549271 |
| 52 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.22191357 |
| 53 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.21388414 |
| 54 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.20331219 |
| 55 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.16559467 |
| 56 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.16445322 |
| 57 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.15994361 |
| 58 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.15548556 |
| 59 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.14594135 |
| 60 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.14051136 |
| 61 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.13063063 |
| 62 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.08950346 |
| 63 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.08324025 |
| 64 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.08238732 |
| 65 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.08212436 |
| 66 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.08182801 |
| 67 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.07800141 |
| 68 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.07629147 |
| 69 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.07263721 |
| 70 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 1.06376147 |
| 71 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.03861242 |
| 72 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.03016032 |
| 73 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.02761950 |
| 74 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.02499844 |
| 75 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.99327636 |
| 76 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.98613432 |
| 77 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.98273146 |
| 78 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.98156318 |
| 79 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.98113118 |
| 80 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.97815621 |
| 81 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.97684914 |
| 82 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.97354842 |
| 83 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.96466281 |
| 84 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.95893887 |
| 85 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.95825461 |
| 86 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95502438 |
| 87 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.94744363 |
| 88 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.94454399 |
| 89 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.94353117 |
| 90 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.93194720 |
| 91 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.93071782 |
| 92 | GATA2_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.92901760 |
| 93 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.92504871 |
| 94 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.91966957 |
| 95 | P68_20966046_ChIP-Seq_HELA_Human | 0.91890772 |
| 96 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.91431072 |
| 97 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.90912469 |
| 98 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.89957921 |
| 99 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.89631437 |
| 100 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.89357047 |
| 101 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.88907497 |
| 102 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.88142160 |
| 103 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.88028463 |
| 104 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.87197715 |
| 105 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.86819458 |
| 106 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.86371429 |
| 107 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.86371429 |
| 108 | * NANOG_20526341_ChIP-Seq_ESCs_Human | 0.86259770 |
| 109 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.86013876 |
| 110 | * RAC3_21632823_ChIP-Seq_H3396_Human | 0.85360047 |
| 111 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.84852323 |
| 112 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.84107336 |
| 113 | MAF_26560356_Chip-Seq_TH1_Human | 0.83532237 |
| 114 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.83008375 |
| 115 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.82786877 |
| 116 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.82477015 |
| 117 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.82468843 |
| 118 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.82211180 |
| 119 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.82204232 |
| 120 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.81261088 |
| 121 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.80962623 |
| 122 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.80456565 |
| 123 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.80394976 |
| 124 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.79308704 |
| 125 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.78440308 |
| 126 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.78259698 |
| 127 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.78239713 |
| 128 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.78093656 |
| 129 | ATF3_27146783_Chip-Seq_COLON_Human | 0.78047538 |
| 130 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.77444068 |
| 131 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.77405151 |
| 132 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.75141886 |
| 133 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.75014077 |
| 134 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.74763781 |
| 135 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.72480943 |
| 136 | * GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.72290564 |
| 137 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.69720890 |
| 138 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.69023752 |
| 139 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.67791525 |
| 140 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.67413399 |
| 141 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.67413399 |
| 142 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.66156020 |
| 143 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.66133221 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004145_abnormal_muscle_electrophysio | 8.52726981 |
| 2 | MP0003646_muscle_fatigue | 6.59690294 |
| 3 | MP0000749_muscle_degeneration | 6.49153189 |
| 4 | MP0000751_myopathy | 5.57786838 |
| 5 | MP0000747_muscle_weakness | 4.55136847 |
| 6 | MP0002106_abnormal_muscle_physiology | 4.33127314 |
| 7 | MP0004036_abnormal_muscle_relaxation | 4.09003501 |
| 8 | MP0000759_abnormal_skeletal_muscle | 3.91052112 |
| 9 | MP0002269_muscular_atrophy | 3.70272014 |
| 10 | MP0005369_muscle_phenotype | 3.60046414 |
| 11 | MP0004130_abnormal_muscle_cell | 3.40893230 |
| 12 | MP0004087_abnormal_muscle_fiber | 3.39451534 |
| 13 | MP0002837_dystrophic_cardiac_calcinosis | 3.23485222 |
| 14 | MP0000750_abnormal_muscle_regeneration | 3.17934087 |
| 15 | MP0005620_abnormal_muscle_contractility | 3.17700334 |
| 16 | MP0004233_abnormal_muscle_weight | 2.72801635 |
| 17 | MP0000733_abnormal_muscle_development | 2.37439061 |
| 18 | MP0002332_abnormal_exercise_endurance | 2.25034401 |
| 19 | MP0002108_abnormal_muscle_morphology | 2.06663393 |
| 20 | MP0006036_abnormal_mitochondrial_physio | 1.94156728 |
| 21 | MP0005330_cardiomyopathy | 1.74896016 |
| 22 | MP0004185_abnormal_adipocyte_glucose | 1.73001786 |
| 23 | MP0002971_abnormal_brown_adipose | 1.42291431 |
| 24 | MP0005666_abnormal_adipose_tissue | 1.39403837 |
| 25 | MP0003806_abnormal_nucleotide_metabolis | 1.39361293 |
| 26 | MP0004084_abnormal_cardiac_muscle | 1.37589499 |
| 27 | MP0004270_analgesia | 1.36157932 |
| 28 | MP0003221_abnormal_cardiomyocyte_apopto | 1.16255289 |
| 29 | MP0002972_abnormal_cardiac_muscle | 1.14331456 |
| 30 | MP0004484_altered_response_of | 1.14277868 |
| 31 | MP0004215_abnormal_myocardial_fiber | 1.13455364 |
| 32 | MP0001661_extended_life_span | 1.12336896 |
| 33 | MP0010630_abnormal_cardiac_muscle | 1.09048758 |
| 34 | MP0006035_abnormal_mitochondrial_morpho | 1.07009960 |
| 35 | MP0005266_abnormal_metabolism | 1.06758134 |
| 36 | MP0005375_adipose_tissue_phenotype | 1.03163731 |
| 37 | MP0004134_abnormal_chest_morphology | 0.97778715 |
| 38 | MP0000013_abnormal_adipose_tissue | 0.96157552 |
| 39 | MP0003656_abnormal_erythrocyte_physiolo | 0.89324383 |
| 40 | MP0004147_increased_porphyrin_level | 0.86123769 |
| 41 | MP0003950_abnormal_plasma_membrane | 0.80630007 |
| 42 | MP0001544_abnormal_cardiovascular_syste | 0.77474543 |
| 43 | MP0005385_cardiovascular_system_phenoty | 0.77474543 |
| 44 | MP0000372_irregular_coat_pigmentation | 0.77297861 |
| 45 | MP0003705_abnormal_hypodermis_morpholog | 0.73730195 |
| 46 | MP0009780_abnormal_chondrocyte_physiolo | 0.72405817 |
| 47 | MP0009250_abnormal_appendicular_skeleto | 0.70805843 |
| 48 | MP0008961_abnormal_basal_metabolism | 0.70217216 |
| 49 | MP0005334_abnormal_fat_pad | 0.67572948 |
| 50 | MP0004043_abnormal_pH_regulation | 0.67034225 |
| 51 | MP0003879_abnormal_hair_cell | 0.66932825 |
| 52 | MP0001299_abnormal_eye_distance/ | 0.66694265 |
| 53 | MP0002078_abnormal_glucose_homeostasis | 0.64730569 |
| 54 | MP0003137_abnormal_impulse_conducting | 0.64119992 |
| 55 | MP0005083_abnormal_biliary_tract | 0.62461047 |
| 56 | MP0005670_abnormal_white_adipose | 0.56037122 |
| 57 | MP0000003_abnormal_adipose_tissue | 0.53701161 |
| 58 | MP0002234_abnormal_pharynx_morphology | 0.52075967 |
| 59 | MP0000762_abnormal_tongue_morphology | 0.51714737 |
| 60 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.51086689 |
| 61 | MP0003959_abnormal_lean_body | 0.49410290 |
| 62 | MP0000343_altered_response_to | 0.49327992 |
| 63 | MP0000266_abnormal_heart_morphology | 0.48971666 |
| 64 | MP0005452_abnormal_adipose_tissue | 0.48411166 |
| 65 | MP0005275_abnormal_skin_tensile | 0.47450985 |
| 66 | MP0002089_abnormal_postnatal_growth/wei | 0.47428995 |
| 67 | MP0004142_abnormal_muscle_tone | 0.44580366 |
| 68 | MP0002127_abnormal_cardiovascular_syste | 0.44239688 |
| 69 | MP0008569_lethality_at_weaning | 0.44135626 |
| 70 | MP0005167_abnormal_blood-brain_barrier | 0.43677219 |
| 71 | MP0003045_fibrosis | 0.42884974 |
| 72 | MP0001346_abnormal_lacrimal_gland | 0.42721456 |
| 73 | MP0002638_abnormal_pupillary_reflex | 0.42301748 |
| 74 | MP0010030_abnormal_orbit_morphology | 0.42131465 |
| 75 | MP0008775_abnormal_heart_ventricle | 0.41854340 |
| 76 | MP0002896_abnormal_bone_mineralization | 0.39949814 |
| 77 | MP0009672_abnormal_birth_weight | 0.37796957 |
| 78 | MP0005319_abnormal_enzyme/_coenzyme | 0.35620174 |
| 79 | MP0001849_ear_inflammation | 0.34074840 |
| 80 | MP0002114_abnormal_axial_skeleton | 0.33168136 |
| 81 | MP0009115_abnormal_fat_cell | 0.31767438 |
| 82 | MP0002734_abnormal_mechanical_nocicepti | 0.31009419 |
| 83 | MP0003948_abnormal_gas_homeostasis | 0.30185505 |
| 84 | MP0005332_abnormal_amino_acid | 0.28012867 |
| 85 | MP0004510_myositis | 0.27410072 |
| 86 | MP0005376_homeostasis/metabolism_phenot | 0.26918723 |
| 87 | MP0003195_calcinosis | 0.26399911 |
| 88 | MP0005423_abnormal_somatic_nervous | 0.26073911 |
| 89 | MP0000230_abnormal_systemic_arterial | 0.25902577 |
| 90 | MP0005535_abnormal_body_temperature | 0.25889986 |
| 91 | MP0005187_abnormal_penis_morphology | 0.25487632 |
| 92 | MP0002118_abnormal_lipid_homeostasis | 0.25279737 |
| 93 | MP0001853_heart_inflammation | 0.25119956 |
| 94 | MP0001243_abnormal_dermal_layer | 0.24520227 |
| 95 | MP0005165_increased_susceptibility_to | 0.24488369 |
| 96 | MP0002139_abnormal_hepatobiliary_system | 0.22749147 |
| 97 | MP0000383_abnormal_hair_follicle | 0.22304864 |
| 98 | MP0008770_decreased_survivor_rate | 0.22062631 |
| 99 | MP0006138_congestive_heart_failure | 0.21640745 |
| 100 | MP0005166_decreased_susceptibility_to | 0.21090382 |
| 101 | MP0002876_abnormal_thyroid_physiology | 0.20537562 |
| 102 | MP0001943_abnormal_respiration | 0.20343715 |
| 103 | MP0005503_abnormal_tendon_morphology | 0.19193437 |
| 104 | MP0002822_catalepsy | 0.19104226 |
| 105 | MP0004858_abnormal_nervous_system | 0.18877281 |
| 106 | MP0005076_abnormal_cell_differentiation | 0.18492667 |
| 107 | MP0002066_abnormal_motor_capabilities/c | 0.18135466 |
| 108 | MP0005451_abnormal_body_composition | 0.17869196 |
| 109 | MP0004085_abnormal_heartbeat | 0.17427393 |
| 110 | MP0003828_pulmonary_edema | 0.16887582 |
| 111 | MP0002128_abnormal_blood_circulation | 0.16572063 |
| 112 | MP0003567_abnormal_fetal_cardiomyocyte | 0.16005304 |
| 113 | MP0002970_abnormal_white_adipose | 0.15988945 |
| 114 | MP0006276_abnormal_autonomic_nervous | 0.15474881 |
| 115 | MP0005645_abnormal_hypothalamus_physiol | 0.14953850 |
| 116 | MP0002067_abnormal_sensory_capabilities | 0.14730764 |
| 117 | MP0003956_abnormal_body_size | 0.14374921 |
| 118 | MP0003941_abnormal_skin_development | 0.12767386 |
| 119 | MP0004197_abnormal_fetal_growth/weight/ | 0.12548658 |
| 120 | MP0004924_abnormal_behavior | 0.11853534 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 9.69233248 |
| 2 | Nemaline bodies (HP:0003798) | 9.13496783 |
| 3 | Exercise-induced myalgia (HP:0003738) | 9.07309760 |
| 4 | Distal arthrogryposis (HP:0005684) | 7.44206111 |
| 5 | Type 1 muscle fiber predominance (HP:0003803) | 7.34953679 |
| 6 | Muscle hypertrophy of the lower extremities (HP:0008968) | 7.21538489 |
| 7 | Myopathic facies (HP:0002058) | 6.97629989 |
| 8 | Round ear (HP:0100830) | 6.37006632 |
| 9 | * Exercise-induced muscle cramps (HP:0003710) | 6.29994743 |
| 10 | Ulnar deviation of the wrist (HP:0003049) | 6.28999375 |
| 11 | Calf muscle hypertrophy (HP:0008981) | 6.25376538 |
| 12 | Difficulty running (HP:0009046) | 5.61106967 |
| 13 | Calcaneovalgus deformity (HP:0001848) | 5.47924836 |
| 14 | Myoglobinuria (HP:0002913) | 5.41427969 |
| 15 | Muscle fiber splitting (HP:0003555) | 5.14592306 |
| 16 | Absent phalangeal crease (HP:0006109) | 5.13059685 |
| 17 | Muscle stiffness (HP:0003552) | 5.09918219 |
| 18 | Deformed tarsal bones (HP:0008119) | 5.01945499 |
| 19 | Hyporeflexia of lower limbs (HP:0002600) | 4.70558085 |
| 20 | EMG: myopathic abnormalities (HP:0003458) | 4.56943217 |
| 21 | Increased connective tissue (HP:0009025) | 4.38926285 |
| 22 | Myotonia (HP:0002486) | 4.34006996 |
| 23 | Abnormal finger flexion creases (HP:0006143) | 4.29774540 |
| 24 | Abnormality of the calf musculature (HP:0001430) | 4.04476792 |
| 25 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.80072559 |
| 26 | Malignant hyperthermia (HP:0002047) | 3.71437816 |
| 27 | Subaortic stenosis (HP:0001682) | 3.69761681 |
| 28 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.69761681 |
| 29 | Rimmed vacuoles (HP:0003805) | 3.52433217 |
| 30 | * Rhabdomyolysis (HP:0003201) | 3.49546392 |
| 31 | Pelvic girdle muscle weakness (HP:0003749) | 3.45206206 |
| 32 | Shoulder girdle muscle weakness (HP:0003547) | 3.45184923 |
| 33 | Neck muscle weakness (HP:0000467) | 3.44735956 |
| 34 | Difficulty climbing stairs (HP:0003551) | 3.37583742 |
| 35 | Increased variability in muscle fiber diameter (HP:0003557) | 3.36249127 |
| 36 | Abnormality of the musculature of the pelvis (HP:0001469) | 3.33306033 |
| 37 | Abnormality of the hip-girdle musculature (HP:0001445) | 3.33306033 |
| 38 | Abnormality of the calcaneus (HP:0008364) | 3.31954063 |
| 39 | Frequent falls (HP:0002359) | 3.22289395 |
| 40 | Hyperkalemia (HP:0002153) | 3.21871364 |
| 41 | Areflexia of lower limbs (HP:0002522) | 3.17294200 |
| 42 | Asymmetric septal hypertrophy (HP:0001670) | 2.93269442 |
| 43 | Bundle branch block (HP:0011710) | 2.91226205 |
| 44 | Paralysis (HP:0003470) | 2.76165133 |
| 45 | Slender build (HP:0001533) | 2.65664507 |
| 46 | Abnormality of the neuromuscular junction (HP:0003398) | 2.63848952 |
| 47 | Fatigable weakness (HP:0003473) | 2.63848952 |
| 48 | EMG: neuropathic changes (HP:0003445) | 2.46430069 |
| 49 | Distal lower limb muscle weakness (HP:0009053) | 2.45062109 |
| 50 | Sudden death (HP:0001699) | 2.43777925 |
| 51 | Dilated cardiomyopathy (HP:0001644) | 2.40904735 |
| 52 | Muscular dystrophy (HP:0003560) | 2.39696707 |
| 53 | Limb-girdle muscle weakness (HP:0003325) | 2.33229409 |
| 54 | Hypoplastic ischia (HP:0003175) | 2.29059275 |
| 55 | Proximal amyotrophy (HP:0007126) | 2.26096611 |
| 56 | Nonprogressive disorder (HP:0003680) | 2.23168366 |
| 57 | Generalized muscle weakness (HP:0003324) | 2.20353357 |
| 58 | Bulbar palsy (HP:0001283) | 2.17309200 |
| 59 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.16126180 |
| 60 | Metatarsus adductus (HP:0001840) | 2.11780813 |
| 61 | Ulnar deviation of finger (HP:0009465) | 2.11619508 |
| 62 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.10660789 |
| 63 | Lipoatrophy (HP:0100578) | 2.09543829 |
| 64 | Abnormality of the shoulder girdle musculature (HP:0001435) | 2.05331623 |
| 65 | Facial diplegia (HP:0001349) | 2.01839330 |
| 66 | Spinal rigidity (HP:0003306) | 2.00813131 |
| 67 | Abnormality of the ischium (HP:0003174) | 2.00127526 |
| 68 | Muscle fiber inclusion bodies (HP:0100299) | 10.1279605 |
| 69 | Abnormality of the foot musculature (HP:0001436) | 1.99726432 |
| 70 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.97077387 |
| 71 | Progressive muscle weakness (HP:0003323) | 1.96724342 |
| 72 | Limb-girdle muscle atrophy (HP:0003797) | 1.95646741 |
| 73 | Gowers sign (HP:0003391) | 1.94492222 |
| 74 | Weak cry (HP:0001612) | 1.93473758 |
| 75 | Scapular winging (HP:0003691) | 1.91417003 |
| 76 | Distal lower limb amyotrophy (HP:0008944) | 1.89057734 |
| 77 | Heart block (HP:0012722) | 1.85199504 |
| 78 | Foot dorsiflexor weakness (HP:0009027) | 1.83935294 |
| 79 | Achilles tendon contracture (HP:0001771) | 1.81895865 |
| 80 | Increased density of long bones (HP:0006392) | 1.80514615 |
| 81 | Stridor (HP:0010307) | 1.78065096 |
| 82 | Waddling gait (HP:0002515) | 1.76218638 |
| 83 | Ragged-red muscle fibers (HP:0003200) | 1.74986531 |
| 84 | Abnormal atrioventricular conduction (HP:0005150) | 1.73371696 |
| 85 | Increased purine levels (HP:0004368) | 1.72422682 |
| 86 | Hyperuricemia (HP:0002149) | 1.72422682 |
| 87 | Tarsal synostosis (HP:0008368) | 1.67810013 |
| 88 | Short palpebral fissure (HP:0012745) | 1.66665187 |
| 89 | Ulnar deviation of the hand or of fingers of the hand (HP:0001193) | 1.66387686 |
| 90 | Abnormality of potassium homeostasis (HP:0011042) | 1.66294617 |
| 91 | Abnormality of the Achilles tendon (HP:0005109) | 1.66103661 |
| 92 | Cholelithiasis (HP:0001081) | 1.62840264 |
| 93 | Gout (HP:0001997) | 1.62645625 |
| 94 | Fetal akinesia sequence (HP:0001989) | 1.61987938 |
| 95 | Popliteal pterygium (HP:0009756) | 1.60177098 |
| 96 | Ventricular tachycardia (HP:0004756) | 1.59430299 |
| 97 | Oligomenorrhea (HP:0000876) | 1.53640875 |
| 98 | Type 2 muscle fiber atrophy (HP:0003554) | 1.53614807 |
| 99 | Increased intramyocellular lipid droplets (HP:0012240) | 1.53040677 |
| 100 | Synostosis involving bones of the feet (HP:0009140) | 1.51283247 |
| 101 | Synostosis involving bones of the lower limbs (HP:0009138) | 1.51283247 |
| 102 | Hip contracture (HP:0003273) | 1.50777334 |
| 103 | Ventricular arrhythmia (HP:0004308) | 1.49527168 |
| 104 | Adducted thumb (HP:0001181) | 1.48453047 |
| 105 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.47298110 |
| 106 | Long clavicles (HP:0000890) | 1.44969123 |
| 107 | Limited hip movement (HP:0008800) | 1.44795267 |
| 108 | Exercise intolerance (HP:0003546) | 1.44459052 |
| 109 | Congenital hip dislocation (HP:0001374) | 1.44247257 |
| 110 | Abnormal gallbladder morphology (HP:0012437) | 1.44075923 |
| 111 | Hypokalemia (HP:0002900) | 1.43772564 |
| 112 | Increased muscle lipid content (HP:0009058) | 1.42351969 |
| 113 | Muscle fiber atrophy (HP:0100295) | 1.41754072 |
| 114 | Toxemia of pregnancy (HP:0100603) | 1.41180591 |
| 115 | Lower limb amyotrophy (HP:0007210) | 1.38313967 |
| 116 | Steppage gait (HP:0003376) | 1.35817664 |
| 117 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.30543114 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 8.48177986 |
| 2 | TTN | 6.40359608 |
| 3 | PHKG1 | 5.88284903 |
| 4 | PHKG2 | 5.88284903 |
| 5 | NME1 | 4.53452655 |
| 6 | PIK3CG | 3.55825637 |
| 7 | MAP2K3 | 3.09734172 |
| 8 | NEK1 | 2.25825350 |
| 9 | MAP3K7 | 2.25350449 |
| 10 | PINK1 | 2.17156321 |
| 11 | PDK4 | 1.83085903 |
| 12 | PDK3 | 1.83085903 |
| 13 | MAP2K4 | 1.74293860 |
| 14 | MAPK12 | 1.70119209 |
| 15 | PIK3CA | 1.69401928 |
| 16 | DMPK | 1.68956787 |
| 17 | TRIB3 | 1.56102878 |
| 18 | BCKDK | 1.53771447 |
| 19 | MAP2K6 | 1.53675976 |
| 20 | PDK2 | 1.22523971 |
| 21 | MUSK | 1.14840654 |
| 22 | PRKAA2 | 0.97053233 |
| 23 | MARK1 | 0.96381150 |
| 24 | NEK9 | 0.95179537 |
| 25 | PRKAA1 | 0.88044974 |
| 26 | MAP3K3 | 0.81046227 |
| 27 | TAOK2 | 0.79078233 |
| 28 | ERBB3 | 0.79022389 |
| 29 | TRPM7 | 0.76923340 |
| 30 | MAPKAPK3 | 0.73198592 |
| 31 | STK24 | 0.73185454 |
| 32 | MAP3K13 | 0.70335457 |
| 33 | MAPK11 | 0.64082936 |
| 34 | CAMK4 | 0.58066729 |
| 35 | ZAK | 0.57172866 |
| 36 | CAMK2G | 0.55746116 |
| 37 | AKT2 | 0.52144407 |
| 38 | MAP3K11 | 0.51687788 |
| 39 | PKN2 | 0.50147256 |
| 40 | EPHB1 | 0.48507845 |
| 41 | SIK1 | 0.47697847 |
| 42 | TAOK1 | 0.47474066 |
| 43 | CAMK1 | 0.40964847 |
| 44 | CAMK2B | 0.40332651 |
| 45 | EEF2K | 0.39990091 |
| 46 | RIPK1 | 0.39509269 |
| 47 | CAMK2A | 0.38434357 |
| 48 | MAP3K6 | 0.37672974 |
| 49 | PTK6 | 0.36380840 |
| 50 | ILK | 0.35928438 |
| 51 | LIMK1 | 0.33203944 |
| 52 | TBK1 | 0.33029099 |
| 53 | SGK2 | 0.32845961 |
| 54 | SGK1 | 0.32234245 |
| 55 | PKN1 | 0.30380524 |
| 56 | MAP3K5 | 0.28099865 |
| 57 | PRKACB | 0.26015351 |
| 58 | PRKG1 | 0.25218473 |
| 59 | RPS6KA3 | 0.25071790 |
| 60 | MAPK7 | 0.24618439 |
| 61 | KSR2 | 0.24542583 |
| 62 | MAP3K1 | 0.24393629 |
| 63 | MAPK13 | 0.24313668 |
| 64 | MAP3K10 | 0.23382731 |
| 65 | TYK2 | 0.21310401 |
| 66 | PRPF4B | 0.20820504 |
| 67 | MAPK4 | 0.20494686 |
| 68 | RPS6KB2 | 0.19813871 |
| 69 | MARK2 | 0.18173570 |
| 70 | PRKACA | 0.17289692 |
| 71 | ARAF | 0.16579215 |
| 72 | DAPK2 | 0.16578262 |
| 73 | CDK19 | 0.16351892 |
| 74 | CAMK1G | 0.16276246 |
| 75 | PDK1 | 0.13273810 |
| 76 | PDPK1 | 0.13233057 |
| 77 | PAK6 | 0.13139169 |
| 78 | SGK494 | 0.13103837 |
| 79 | SGK223 | 0.13103837 |
| 80 | ROCK1 | 0.11737431 |
| 81 | TIE1 | 0.11692623 |
| 82 | INSRR | 0.11503170 |
| 83 | RAF1 | 0.11393752 |
| 84 | RPS6KC1 | 0.11164735 |
| 85 | RPS6KL1 | 0.11164735 |
| 86 | ZAP70 | 0.10309650 |
| 87 | PRKD1 | 0.09237391 |
| 88 | MAP2K1 | 0.08915720 |
| 89 | DYRK1B | 0.08334964 |
| 90 | RPS6KA6 | 0.08079524 |
| 91 | TGFBR2 | 0.07978320 |
| 92 | NLK | 0.06974358 |
| 93 | RPS6KA1 | 0.06854022 |
| 94 | MOS | 0.06275472 |
| 95 | SGK3 | 0.06022625 |
| 96 | JAK2 | 0.05448048 |
| 97 | LRRK2 | 0.05403608 |
| 98 | ICK | 0.04979027 |
| 99 | BMX | 0.04860695 |
| 100 | BRAF | 0.04489751 |
| 101 | PRKACG | 0.04438316 |
| 102 | MAPK10 | 0.04201820 |
| 103 | FGFR3 | 0.03941030 |
| 104 | STK11 | 0.02464796 |
| 105 | GSK3B | 0.02353735 |
| 106 | CAMK2D | 0.02142243 |
| 107 | MAPK8 | 0.01947599 |
| 108 | MTOR | 0.01880058 |
| 109 | MAPK3 | 0.01758587 |
| 110 | CSNK1D | 0.01582090 |
| 111 | LATS1 | 0.01521222 |
| 112 | EPHA3 | 0.01297913 |
| 113 | FGFR1 | 0.01180387 |
| 114 | GSK3A | 0.00982927 |
| 115 | PNCK | 0.00741554 |
| 116 | CCNB1 | 0.00327742 |
| 117 | MARK3 | -0.0361396 |
| 118 | MAP3K8 | -0.0313701 |
| 119 | HCK | -0.0296802 |
| 120 | PRKCH | -0.0294704 |
| 121 | RPS6KB1 | -0.0230955 |
| 122 | PTK2B | -0.0196181 |
| 123 | MAPK9 | -0.0170964 |
| 124 | PRKDC | -0.0151106 |
| 125 | MAP3K4 | -0.0127191 |
| 126 | RPS6KA2 | -0.0122407 |
| 127 | KSR1 | -0.0070485 |
| 128 | LATS2 | -0.0005631 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 4.30289077 |
| 2 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.10576517 |
| 3 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 3.74911824 |
| 4 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 3.56028149 |
| 5 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.32481569 |
| 6 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.25231968 |
| 7 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 3.24693421 |
| 8 | Circadian rhythm_Homo sapiens_hsa04710 | 2.73885562 |
| 9 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 2.55577425 |
| 10 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 2.40845218 |
| 11 | Insulin signaling pathway_Homo sapiens_hsa04910 | 2.39518681 |
| 12 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.36090766 |
| 13 | Insulin resistance_Homo sapiens_hsa04931 | 2.24572867 |
| 14 | Carbon metabolism_Homo sapiens_hsa01200 | 2.18072539 |
| 15 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 2.09853379 |
| 16 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.03703894 |
| 17 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.90476680 |
| 18 | Galactose metabolism_Homo sapiens_hsa00052 | 1.88108246 |
| 19 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.82036819 |
| 20 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.79831735 |
| 21 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.71193415 |
| 22 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.66852120 |
| 23 | Parkinsons disease_Homo sapiens_hsa05012 | 1.62910888 |
| 24 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.58295997 |
| 25 | Alzheimers disease_Homo sapiens_hsa05010 | 1.56349061 |
| 26 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.52115084 |
| 27 | Viral myocarditis_Homo sapiens_hsa05416 | 1.47043729 |
| 28 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.42411359 |
| 29 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.42145531 |
| 30 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.36863041 |
| 31 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.35800952 |
| 32 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.33564729 |
| 33 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.28957576 |
| 34 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.27114844 |
| 35 | Tight junction_Homo sapiens_hsa04530 | 1.25017756 |
| 36 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.22077530 |
| 37 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.18948461 |
| 38 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.07874567 |
| 39 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.06710273 |
| 40 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.04002834 |
| 41 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.01253098 |
| 42 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.97479606 |
| 43 | Focal adhesion_Homo sapiens_hsa04510 | 0.94521301 |
| 44 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.91946594 |
| 45 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.89457154 |
| 46 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.86534113 |
| 47 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.84720564 |
| 48 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.74070076 |
| 49 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.70649101 |
| 50 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.70433274 |
| 51 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.70267942 |
| 52 | Renin secretion_Homo sapiens_hsa04924 | 0.62008385 |
| 53 | Huntingtons disease_Homo sapiens_hsa05016 | 0.60776959 |
| 54 | Platelet activation_Homo sapiens_hsa04611 | 0.58941110 |
| 55 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.58280165 |
| 56 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.57056008 |
| 57 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.51901556 |
| 58 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.49789284 |
| 59 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.49732057 |
| 60 | Insulin secretion_Homo sapiens_hsa04911 | 0.47266837 |
| 61 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.46579122 |
| 62 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.43069087 |
| 63 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.42724666 |
| 64 | Salivary secretion_Homo sapiens_hsa04970 | 0.41643968 |
| 65 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.41039643 |
| 66 | Adherens junction_Homo sapiens_hsa04520 | 0.36678934 |
| 67 | Amoebiasis_Homo sapiens_hsa05146 | 0.34567298 |
| 68 | Lysine degradation_Homo sapiens_hsa00310 | 0.34411401 |
| 69 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.32806395 |
| 70 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.32402566 |
| 71 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.31847273 |
| 72 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.29736128 |
| 73 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.26442735 |
| 74 | Histidine metabolism_Homo sapiens_hsa00340 | 0.26161828 |
| 75 | Long-term depression_Homo sapiens_hsa04730 | 0.25465079 |
| 76 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.24871309 |
| 77 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.24297877 |
| 78 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.23997432 |
| 79 | Glioma_Homo sapiens_hsa05214 | 0.22411388 |
| 80 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.21312121 |
| 81 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.20521540 |
| 82 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.20362513 |
| 83 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.19404724 |
| 84 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.18770947 |
| 85 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.18077418 |
| 86 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.17259978 |
| 87 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.17076609 |
| 88 | Thyroid cancer_Homo sapiens_hsa05216 | 0.16224565 |
| 89 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.16100137 |
| 90 | Peroxisome_Homo sapiens_hsa04146 | 0.15676613 |
| 91 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.13386219 |
| 92 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.13370028 |
| 93 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.13106440 |
| 94 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.13010850 |
| 95 | ABC transporters_Homo sapiens_hsa02010 | 0.12833333 |
| 96 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.11829069 |
| 97 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.10457924 |
| 98 | Melanogenesis_Homo sapiens_hsa04916 | 0.09917983 |
| 99 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.08084089 |
| 100 | Sulfur relay system_Homo sapiens_hsa04122 | 0.08081284 |
| 101 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.08017684 |
| 102 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.07567840 |
| 103 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.06687291 |
| 104 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.05987162 |
| 105 | Olfactory transduction_Homo sapiens_hsa04740 | 0.05800129 |
| 106 | Long-term potentiation_Homo sapiens_hsa04720 | 0.05600180 |
| 107 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.05101350 |
| 108 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.04383327 |
| 109 | Leishmaniasis_Homo sapiens_hsa05140 | 0.04058551 |
| 110 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.03761560 |
| 111 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.03205493 |
| 112 | Circadian entrainment_Homo sapiens_hsa04713 | 0.02997604 |
| 113 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.02261638 |
| 114 | Bile secretion_Homo sapiens_hsa04976 | 0.02095753 |
| 115 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.01940848 |
| 116 | Legionellosis_Homo sapiens_hsa05134 | 0.01142260 |
| 117 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.00985306 |

